Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 141,900 shares, an increase of 27.2% from the January 15th total of 111,600 shares. Approximately 11.4% of the company’s shares are short sold. Based on an average trading volume of 401,600 shares, the short-interest ratio is presently 0.4 days.
Autonomix Medical Stock Down 0.4 %
Shares of NASDAQ:AMIX opened at $2.84 on Friday. The firm has a 50 day simple moving average of $3.12 and a 200 day simple moving average of $9.05. Autonomix Medical has a 52 week low of $2.55 and a 52 week high of $99.60. The company has a debt-to-equity ratio of 0.36, a quick ratio of 4.26 and a current ratio of 4.26. The company has a market cap of $3.27 million and a PE ratio of -0.18.
Autonomix Medical (NASDAQ:AMIX – Get Free Report) last released its earnings results on Thursday, February 13th. The company reported ($1.46) earnings per share (EPS) for the quarter. As a group, research analysts expect that Autonomix Medical will post -10 earnings per share for the current year.
Autonomix Medical Company Profile
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Featured Articles
- Five stocks we like better than Autonomix Medical
- How to Use the MarketBeat Excel Dividend Calculator
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Stock Dividend Cuts Happen Are You Ready?
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.